|
|
ARIZONA HOUSE OF REPRESENTATIVES57th Legislature, 2nd Regular Session |
Senate: HHS DP 5-2-0-0 | Third Read 18-8-4-0 |
SB 1052: assisted living; hyperbaric oxygen therapy
Sponsor: Senator Rogers, LD 7
Committee on Health & Human Services
Overview
Allows assisted living homes and centers to offer mild hyperbaric oxygen therapy (mHBOT) to their residents under outlined requirements.
History
Hyperbaric oxygen therapy (HBOT) is a modality in which the entire body is exposed to oxygen under increased atmospheric pressure. HBOT treats a variety of conditions, including chronic wounds. During therapy, patients breathe in 100% oxygen under increased atmospheric pressure. This process allows a patient's lungs to gather more oxygen than normal, and a patient's blood carries the oxygen throughout the body to promote healing. HBOT is also used in treating conditions such as: 1) acute carbon monoxide poisoning; 2) decompression illness; and 3) cyanide poisoning (HonorHealth).
Assisted living centers are an assisted living facility that provides resident rooms or residential units to eleven or more residents. Assisted living homes are assisted living facilities that provide resident rooms to ten or fewer residents. Assisted living facilities are residential care institutions, including adult foster care homes, that provide or contract to provide supervisory, personal or directed care services on a continuous basis (A.R.S. §§ 36-401, 36-407).
Provisions
1. Authorizes assisted living homes and assisted living centers to offer mHBOT to residents under the direction of a physician using a class II mild hyperbaric oxygen chamber that is premarket notification cleared by the U.S. Food and Drug Administration (FDA) for home use. (Sec. 1)
2. Specifies that residents must be able to independently free themselves from the mHBOT. (Sec. 1)
3. Requires assisted living homes and assisted living centers that offers mHBOT to its residents to:
a. allow the use of the mHBOT only by the order of a physician; and
b. ensure that a staff member with manufacturer-approved training is on-site. (Sec. 1)
4. Requires notice to residents receiving mHBOT concerning the FDA approval of the device to treat mild symptoms of acute mountain sickness, potential symptoms and risks, including use that is not explicitly approved by the FDA. (Sec. 1)
5. Prohibits assisted living centers or homes from offering mHBOT to residents who require directed care services, unless:
a. the therapy is provided on the order of the resident's treating physician; and
b. the resident or the resident's authorized representative provides informed consent. (Sec. 1)
6. Allows DHS to adopt any necessary rules for the purpose of allowing the use of mHBOT to residents in assisted living homes and assisted living centers. (Sec. 1)
7.
8.
9. ---------- DOCUMENT FOOTER ---------
10. Initials TM/LK SB 1052
11. 3/18/2026 Page 0 Health & Human Services
12.
13. ---------- DOCUMENT FOOTER ---------